LAST PRICE - AT THE CLOSE
DRUG is DOWN -23% since the begininning of the year
DRUG is DOWN -20% BELOW 20 day SMA
DRUG is DOWN -17% BELOW 200 day SMA
PROFITABLE: NO
EPS: $-0.536582
EARNINGS MOMENTUM: YES
0.14% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
![]() |
THE STOCK IS 51.7% AWAY FROM ALL-TIME HIGHS OF $123.75 |
![]() |
DRUG IS DOWN -23% SINCE THE BEGINNING OF THE YEAR |
![]() |
DRUG IS UP 112% OVER THE PAST 12 MONTHS |
![]() |
DRUG IS DOWN -23% OVER THE PAST 1 MONTH |
![]() |
6% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
![]() |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
![]() |
DRUG moved up 0 in the previous minute |
![]() |
DRUG is up 0.23 over the last hour |
![]() |
DRUG is up 8.4% over the last 5 days |
![]() |
DRUG is 7.9 above its 8 day SMA |
| $56.47 | ![]() DAY |
$60.95 |
| $59.00 | ![]() PREVIOUS DAY |
$62.55 |
| $59.00 | ![]() WEEK |
$69.97 |
| $59.00 | ![]() ![]() MONTH |
$92.00 |
| $0.94 | ![]() ![]() YEAR |
$123.75 |
DRUG is mentioned N/A less than normal on
DRUG is mentioned N/A times in an average day on